Mum fundraises to install mental health bench in Wellingborough - BBC
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Mental health bench shows no-one is alone, says mum4 October 2026Alex PopeNorthamptonshireNorth Northamptonshire CouncilThe bench includes phone numbers and links to support networks that people can reachA mother who organised a bench to be installed for people struggling with mental health issues said it symbolised that people were "not alone". Anne-Marie, from north Northamptonshire, fundraised about £1,265 to have the bench placed along the Embankment in Wellingborough. She said seeing it in situ was a "proud and emotional" moment which honoured her ex-partner, and father of her two sons, who took his own life in 2024. After her partner's death Anne-Marie started The Seddon Legacy Project, a voluntary community group that works to improve access to services for families who have experienced bereavement. The 34-year-old also worked with North Northamptonshire Council, Survivors of Bereavement by Suicide (SoBS) and Kelly's Heroes on the bench, which was supplied by Legend on the Bench, a suicide prevention charity. The bench includes a light for people to help them read contact numbers and QR codes directing people to a help page and 24-hour support services.
This article is an excerpt. To read the full content, visit the original source. BBC
Related articles
Targeted ads delivered 0-click exploits to install mercenary malware - Ars Technica
Among the major vendors that listed Discover-Tech as a “certified” or “verified” vendor were Google and the advertising industry association IAB Europe. The Israeli firm also used European General Data Protection Regulation (GDPR) consent frameworks to target users within the European Union. Discover-Tech has served ads through major networks such as Google, Yandex, and Beeswax. Google and IAB Europe have since removed Discover-Tech from their ad vendor registries, and Google further terminated Discover-Tech’s access to its ad exchange platforms. Beeswax has removed Discover-Tech from its ad buying platform. Fellow ad platform Vungle (Liftoff) paused Discover-Tech’s access while conducting a review, and Eskimi blocked Discover-Tech’s accounts and domains.
Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group
Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
TheBodyPro | What to know about hepatitis B when switching to tenofovir-sparing antiretroviral regimens - European AIDS Treatment Group
TheBodyPro clinical overviewAs we more frequently prescribe injectables, two-drug therapies, and other novel antiretroviral regimens, a growing proportion of those regimens lack tenofovir. Because tenofovir is used to treat hepatitis B virus (HBV) and is partially protective against new HBV infection, providers need to consider the risk of new or reactivated HBV before switching a patient to a tenofovir-sparing regimen. “I think we are very much in, and entering, an era where increasingly more therapeutic options for antiretroviral therapy and PrEP are going to be without tenofovir,” said H. Nina Kim, M. D., M. Sc., a professor of medicine at University of Washington’s Division of Allergy and Infectious Diseases. Kim co-authored a viewpoint paper this May in Clinical Infectious Diseases highlighting the issue so that clinicians can protect patients against potentially harmful reactivations and new HBV infections. “Many of these reactivations may be subclinical with mild rise in liver enzymes,” Kim said.
0 comments
No comments yet. Be the first to share your thoughts!